Latest filing published 01 Mar 2023 for Lexicon Pharmaceuticals, INC..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Kiernan Seth: trading record in brief
All filings by Kiernan Seth on record concern Lexicon Pharmaceuticals, Inc. Between 28 February 2022 and 28 February 2023, the trades on record add up to 8 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 1 March 2023, reports a share grant of €24k in Lexicon Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kiernan Seth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,833 sharesCommon StockSEC:0001127602-23-007932:0
- 10,007 sharesCommon StockSEC:0001127602-22-007175:0
2 of 2 declarations